bf/NASDAQ:CRSP_icon.jpeg

COM:CRISPRTX

CRISPR Therapeutics AG

  • Stock

Last Close

46.29

22/11 21:00

Market Cap

4.72B

Beta: -

Volume Today

1.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
247K
-
5.16M
1,990.69%
41.00M
693.90%
3.12M
92.38%
289.59M
9,169.85%
543K
99.81%
913.08M
168,054.88%
436K
99.95%
370M
84,762.39%
cost of revenue
110.25M
-
130.25M
18.14%
gross profit
247K
-
5.16M
1,990.69%
41.00M
693.90%
3.12M
92.38%
289.59M
9,169.85%
543K
99.81%
913.08M
168,054.88%
-109.81M
112.03%
239.75M
318.32%
selling and marketing expenses
general and administrative expenses
5.11M
-
13.40M
162.08%
31.06M
131.71%
35.84M
15.42%
48.29M
34.73%
63.49M
31.46%
88.21M
38.94%
102.80M
16.54%
102.46M
0.33%
76.16M
25.67%
selling general and administrative expenses
5.11M
-
13.40M
162.08%
31.06M
131.71%
35.84M
15.42%
48.29M
34.73%
63.49M
31.46%
88.21M
38.94%
102.80M
16.54%
102.46M
0.33%
76.16M
25.67%
research and development expenses
1.51M
-
12.57M
731.00%
42.24M
235.94%
69.80M
65.25%
113.77M
63.00%
179.36M
57.65%
266.95M
48.83%
438.63M
64.32%
461.64M
5.25%
387.33M
16.10%
other expenses
-236K
-
16K
106.78%
78.51M
490,600%
-197K
100.25%
-5.49M
2,684.26%
20.57M
474.95%
-176K
100.86%
-1.88M
969.32%
-762K
59.51%
71.82M
9,524.67%
cost and expenses
6.63M
-
25.98M
291.97%
73.29M
182.16%
105.64M
44.14%
162.07M
53.41%
242.85M
49.85%
354.98M
46.17%
539.55M
52.00%
673.60M
24.84%
592.54M
12.03%
operating expenses
6.63M
-
25.98M
291.97%
73.29M
182.16%
105.64M
44.14%
162.07M
53.41%
242.85M
49.85%
354.98M
46.17%
539.55M
52.00%
563.35M
4.41%
462.29M
17.94%
interest expense
108K
-
8.05M
7,353.70%
-46.83M
-
ebitda
-6.83M
-
-25.59M
274.89%
-25.23M
1.41%
-61.62M
144.30%
-158.94M
157.92%
46.74M
129.41%
-345.25M
838.66%
373.53M
208.19%
-673.16M
280.22%
-202.70M
69.89%
operating income
-6.63M
-
-25.73M
288.25%
-68.13M
164.80%
-64.65M
5.11%
-158.94M
145.86%
46.74M
129.41%
-354.44M
858.31%
373.53M
205.39%
-673.16M
280.22%
-222.54M
66.94%
depreciation and amortization
38K
-
127K
234.21%
925K
628.35%
3.02M
226.92%
3.52M
16.37%
4.72M
34.27%
9.18M
94.37%
17.95M
95.48%
24.17M
34.64%
19.84M
17.93%
total other income expenses net
-236K
-
16K
106.78%
53.46M
334,037.50%
-1.96M
103.67%
-5.49M
179.85%
20.57M
474.95%
6.38M
68.98%
6.00M
5.89%
22.66M
277.49%
71.82M
216.91%
income before tax
-6.86M
-
-25.82M
276.23%
-22.72M
12.02%
-66.61M
193.19%
-164.43M
146.86%
67.31M
140.93%
-348.06M
617.12%
379.53M
209.04%
-650.50M
271.40%
-150.72M
76.83%
income tax expense
-63K
-
7K
111.11%
484K
6,814.29%
1.75M
261.36%
553K
68.38%
448K
18.99%
809K
80.58%
1.87M
131.15%
-325K
117.38%
2.89M
988.62%
net income
-6.80M
-
-25.83M
279.82%
-23.20M
10.17%
-68.36M
194.62%
-164.98M
141.35%
66.86M
140.52%
-348.87M
621.80%
377.66M
208.25%
-650.17M
272.16%
-153.61M
76.37%
weighted average shs out
29.30M
-
29.30M
0%
12.26M
58.16%
40.06M
226.80%
47.96M
19.74%
54.39M
13.40%
65.95M
21.25%
75.95M
15.16%
77.75M
2.37%
79.22M
1.90%
weighted average shs out dil
29.30M
-
29.30M
0%
12.26M
58.16%
40.06M
226.80%
47.96M
19.74%
56.93M
18.70%
65.95M
15.84%
80.39M
21.90%
77.75M
3.29%
79.22M
1.90%
eps
-0.23
-
-0.88
282.61%
-1.89
114.77%
-1.71
9.52%
-3.44
101.17%
1.23
135.76%
-5.29
530.08%
4.97
193.95%
-8.36
268.21%
-1.94
76.79%
epsdiluted
-0.23
-
-0.88
282.61%
-1.89
114.77%
-1.71
9.52%
-3.44
101.17%
1.17
134.01%
-5.29
552.14%
4.70
188.85%
-8.36
277.87%
-1.94
76.79%

All numbers in (except ratios and percentages)